Company intelligence
QuidelOrtho
Changing lives one test at a time – Connect with us and explore how we’re shaping the future of diagnostics.
About QuidelOrtho
> Bringing precision and passion in everything we do QuidelOrtho stands at the forefront of testing, tracking and disease analysis of health conditions ranging from HIV and hepatitis C to flu, strep and COVID-19. For decades, our precision and accuracy have guided clinicians and lab technicians in the moments that matter most. > Continuing our legacy in diagnostics Our portfolio serves the entire healthcare continuum: from high-volume, high-complexity hospitals and labs to point-of-care, retail and over-the-counter markets. This enables us to continue our legacy of diagnostics in an ever-changing environment where we're passionately pursuing the unknown to advance diagnostic science and care. > Raising the bar in diagnostic care Ranked among the world’s largest in vitro diagnostics (IVD) providers, we’re building on more than 120 years of collective experience and innovation. We combine industry-leading expertise in immunoassay and molecular testing with a global footprint in point-of-care settings, clinical labs and transfusion medicine to advance critical diagnostic solutions at scale. > Powering a healthier future for all Inspired by a spirit of service, QuidelOrtho is committed to enhancing the wellbeing of people worldwide and happy in the knowledge we are making a difference. To contact us, please visit https://www.quidelortho.com/global/en/contact-us. For career opportunities, please visit: https://careers.quidelortho.com/global/en. #QuidelOrtho #BetterTogether #PowerUpLabs #HealthierFuture #DiagnosticFrontier #AdvancingScience #TalentNetwork
Verified activity
Signals from QuidelOrtho
9 published signals
Presence & Recognition
QuidelOrtho Corporation is hosting a P.A.C.E.-accredited webinar titled maternal alloimmunization and its role in hemolytic disease of the fetus and newborn (HDFN) on Tuesday, September 22, 2026, featuring speakers Bethany Weathersby, Molly Sherwood, and Michelle Mullens.
Reported by QuidelOrtho
Partnerships
QuidelOrtho has chosen Ambulancedienst Zuid-Holland Zuid for high-sensitivity Troponine-I point-of-care testing for ambulance services.
Reported by Jamal Safssafi
Presence & Recognition
QuidelOrtho Science Bytes featured Dr. Mike Broyles discussing sepsis in episode 45.
Reported by QuidelOrtho
Operations & Supply
QuidelOrtho experienced a disruption in its supply chain operations that sharpens its instincts for future disruptions.
Reported by Boubacar Oumar
Research & Knowledge
QuidelOrtho published a study in The Lancet Digital Health showing how AI can predict prehospital transfusion needs for trauma patients.
Reported by Thomas Gelsing Carlsen, PhD
Presence & Recognition
QuidelOrtho Corporation is hosting a P.A.C.E.-accredited webinar featuring The Allo Hope Foundation on Tuesday, September 22, 2026, 11:00 a.m. ET to explore maternal alloimmunization and hemolytic disease of the fetus and newborn.
Reported by QuidelOrtho
Presence & Recognition
QuidelOrtho supports patients, families and care teams living with and treating sickle cell disease during the SickleCell Awareness Month.
Reported by QuidelOrtho
Research & Knowledge
QuidelOrtho released Episode 59 of QuidelOrtho Science Bytes discussing testing, prevention, and compassionate care.
Reported by QuidelOrtho
Research & Knowledge
QuidelOrtho released Episode 49 of QuidelOrtho Science Bytes detailing urgent diagnostics to prevent overdose deaths.
Reported by QuidelOrtho